Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	42.78	38.66	27.08
Graham Fair Price	-88.48	381.26	3310.33
PEG	1503.26	-11.66	0.73
Price/Book	9.24	0.71	0.65
Price/Cash Flow	150.24	-39.05	15.61
Prices/Earnings	7971.96	1149.88	14.25
Price/Sales	10.69	3.51	3.17
Price/FCF	150.24	-39.05	15.61
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	39.37	0.12	0.09
Operating Margin	-30.05	0.08	0.11
ROA	-98.66	< 0.005	< 0.005
ROE	0.01	< 0.005	-98.65
ROIC	0.01	< 0.005	-72.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.06	0.01	452.80
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.29	-0.31	9.85
EPS QOQ	0.20	-0.99	403.47
FCF QOQ	0.22	-1.43	555.84
Revenue QOQ	0.06	-0.02	-64.21
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	129.26	147.16	13.84
Days Sales Outstanding (DSO)	42.63	46.26	8.53
Inventory Turnover	0.70	0.61	-12.16
Debt/Capitalization	0.24	0.23	-3.86
Quick Ratio	1.03	0.74	-27.90
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6536.05	6470.92	-1.00
Cash	1051.43	581.14	-44.73
Capex	-119.51	-138.36	-15.77
Free Cash Flow	272.07	-117.59	-56.78
Revenue	1338.96	1308.22	-2.30
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.22	1.99	-10.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.36	8.92	66.36
Naive Interpretation	Member

06 - Financial Health · Weak

Rating